Rachel Millner
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Associate Professor
Also affiliated: Arkansas Children's Hospital (2018–2023); Nationwide Children's Hospital (2019); University of Arkansas Medical Center (2018–2023); University of Vermont Children’s Hospital (2015); University of Iowa Stead Family Children’s Hospital (2023)
Peds Pediatrics, College of Medicine
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Rachel Millner's research focuses on pediatric health, with a particular emphasis on nephrology and infectious diseases. She has investigated urinary tract infections and identified potential early markers for renal disease in children with neurogenic bladder, such as albuminuria. Her work also examines adverse reactions to novel therapies, including thrombotic microangiopathy following onasemnogene abeparvovec for spinal muscular atrophy. Millner has contributed to understanding the utilization patterns of treatments like eculizumab for hemolytic uremic syndrome and has explored the relationship between COVID-19 vaccination and new-onset glomerular disease through international registry data. Additionally, her scholarship includes research on quality improvement training in pediatric residency programs and the impact of anti-fat bias in eating disorder psychotherapies. Millner holds an h-index of 5 with 13 publications and 329 citations.
Metrics
- h-index: 5
- Publications: 12
- Citations: 330
Positions
-
Associate Professor publications 2018–2025University of Arkansas for Medical Sciences Peds Pediatrics, College of Medicine Institutional directory
-
University of Arkansas for Medical Sciences publications 2018–2025ORCID
Selected Publications
-
Creating a Roadmap for Longitudinal Quality Improvement Training in a Pediatric Residency Program (2025)
-
Moving the neonatal nephrology field forward: results from the Pediatric Academic Society Neonatal Nephrology Focus Group (2023)
-
Preparing for kidney replacement therapy in pediatric advanced CKD: a review of literature and defining a multi-disciplinary clinical approach to patient-caregiver education (2023)
-
COVID-19 Vaccination and New Onset Glomerular Disease: Results from the IRocGN2 International Registry (2022)
-
Utilization Pattern for Eculizumab Among Children With Hemolytic Uremic Syndrome (2021)
-
Thrombotic Microangiopathy Following Onasemnogene Abeparvovec for Spinal Muscular Atrophy: A Case Series (2020)
Collaboration Network
Top Collaborators
- Thrombotic Microangiopathy Following Onasemnogene Abeparvovec for Spinal Muscular Atrophy: A Case Series
- Moving the neonatal nephrology field forward: results from the Pediatric Academic Society Neonatal Nephrology Focus Group
- Utilization Pattern for Eculizumab Among Children With Hemolytic Uremic Syndrome
- Preparing for kidney replacement therapy in pediatric advanced CKD: a review of literature and defining a multi-disciplinary clinical approach to patient-caregiver education
- Utilization Pattern for Eculizumab Among Children With Hemolytic Uremic Syndrome
- Preparing for kidney replacement therapy in pediatric advanced CKD: a review of literature and defining a multi-disciplinary clinical approach to patient-caregiver education
- Preparing for kidney replacement therapy in pediatric advanced CKD: a review of literature and defining a multi-disciplinary clinical approach to patient-caregiver education
- Moving the neonatal nephrology field forward: results from the Pediatric Academic Society Neonatal Nephrology Focus Group
- Thrombotic Microangiopathy Following Onasemnogene Abeparvovec for Spinal Muscular Atrophy: A Case Series
- Thrombotic Microangiopathy Following Onasemnogene Abeparvovec for Spinal Muscular Atrophy: A Case Series
- Thrombotic Microangiopathy Following Onasemnogene Abeparvovec for Spinal Muscular Atrophy: A Case Series
- Thrombotic Microangiopathy Following Onasemnogene Abeparvovec for Spinal Muscular Atrophy: A Case Series
- Thrombotic Microangiopathy Following Onasemnogene Abeparvovec for Spinal Muscular Atrophy: A Case Series
- Thrombotic Microangiopathy Following Onasemnogene Abeparvovec for Spinal Muscular Atrophy: A Case Series
- Thrombotic Microangiopathy Following Onasemnogene Abeparvovec for Spinal Muscular Atrophy: A Case Series
- Thrombotic Microangiopathy Following Onasemnogene Abeparvovec for Spinal Muscular Atrophy: A Case Series
- Utilization Pattern for Eculizumab Among Children With Hemolytic Uremic Syndrome
- Utilization Pattern for Eculizumab Among Children With Hemolytic Uremic Syndrome
- Utilization Pattern for Eculizumab Among Children With Hemolytic Uremic Syndrome
Similar Researchers
Based on overlapping research topics